Xeris Biopharma Holdings Inc (XERS)
3.09
+0.05
(+1.64%)
USD |
NASDAQ |
Nov 22, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Free Cash Flow: -32.26M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -32.26M |
| June 30, 2024 | -38.83M |
| March 31, 2024 | -43.38M |
| December 31, 2023 | -49.29M |
| September 30, 2023 | -72.88M |
| June 30, 2023 | -75.85M |
| March 31, 2023 | -81.38M |
| December 31, 2022 | -103.42M |
| September 30, 2022 | -116.24M |
| June 30, 2022 | -121.23M |
| March 31, 2022 | -120.64M |
| December 31, 2021 | -96.62M |
| September 30, 2021 | -78.64M |
| June 30, 2021 | -72.68M |
| Date | Value |
|---|---|
| March 31, 2021 | -76.35M |
| December 31, 2020 | -80.94M |
| September 30, 2020 | -99.66M |
| June 30, 2020 | -113.64M |
| March 31, 2020 | -113.07M |
| December 31, 2019 | -105.45M |
| September 30, 2019 | -94.22M |
| June 30, 2019 | -79.96M |
| March 31, 2019 | -71.00M |
| December 31, 2018 | -57.79M |
| September 30, 2018 | -48.54M |
| June 30, 2018 | -37.45M |
| March 31, 2018 | -29.64M |
| December 31, 2017 | -25.36M |
Free Cash Flow Range, Past 5 Years
-121.23M
Minimum
Jun 2022
-32.26M
Maximum
Sep 2024
-84.62M
Average
-81.16M
Median
Free Cash Flow Benchmarks
| Zevra Therapeutics Inc | -69.57M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.305M |
| Cash from Investing (Quarterly) | 9.914M |
| Cash from Financing (Quarterly) | -0.083M |
| Free Cash Flow Per Share (Quarterly) | -0.0563 |
| Free Cash Flow to Equity (Quarterly) | -9.195M |
| Free Cash Flow to Firm (Quarterly) | -2.952M |
| Free Cash Flow Yield | -7.25% |